Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic.

Shivaji UN, Ford AC.

Frontline Gastroenterol. 2014 Oct;5(4):266-271. doi: 10.1136/flgastro-2013-100426. Epub 2014 Jan 21.

2.

Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.

Varjú P, Farkas N, Hegyi P, Garami A, Szabó I, Illés A, Solymár M, Vincze Á, Balaskó M, Pár G, Bajor J, Szűcs Á, Huszár O, Pécsi D, Czimmer J.

PLoS One. 2017 Aug 14;12(8):e0182942. doi: 10.1371/journal.pone.0182942. eCollection 2017.

3.

Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.

Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L.

World J Gastroenterol. 2016 Dec 28;22(48):10631-10642. doi: 10.3748/wjg.v22.i48.10631.

4.

Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey.

Cañón M, Ruiz AJ, Rondón M, Alvarado J.

Ann Gastroenterol. 2017;30(1):67-75. doi: 10.20524/aog.2016.0093. Epub 2016 Sep 30.

5.

Epidemiology of irritable bowel syndrome in the former communist countries from Eastern Europe: a systematic review.

Rusu F, Dumitrascu DL.

Clujul Med. 2015;88(2):146-51. doi: 10.15386/cjmed-449. Epub 2015 Apr 15.

6.

Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study.

Guo YB, Zhuang KM, Kuang L, Zhan Q, Wang XF, Liu SD.

Gut Liver. 2015 Sep 23;9(5):649-56. doi: 10.5009/gnl13437.

7.

A cross-sectional study of risk factors for irritable bowel syndrome in children 8-13 years of age in suzhou, china.

Zhu X, Chen W, Zhu X, Shen Y.

Gastroenterol Res Pract. 2014;2014:198461. doi: 10.1155/2014/198461. Epub 2014 May 11.

8.

Is irritable bowel syndrome an organic disorder?

El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG, Hausken T.

World J Gastroenterol. 2014 Jan 14;20(2):384-400. doi: 10.3748/wjg.v20.i2.384. Review.

9.

The epidemiology of irritable bowel syndrome.

Canavan C, West J, Card T.

Clin Epidemiol. 2014 Feb 4;6:71-80. doi: 10.2147/CLEP.S40245. eCollection 2014. Review.

10.

The duration of gastrointestinal and joint symptoms after a large waterborne outbreak of gastroenteritis in Finland in 2007--a questionnaire-based 15-month follow-up study.

Laine J, Lumio J, Toikkanen S, Virtanen MJ, Uotila T, Korpela M, Kujansuu E, Kuusi M.

PLoS One. 2014 Jan 17;9(1):e85457. doi: 10.1371/journal.pone.0085457. eCollection 2014.

11.

Low prevalence of irritable bowel syndrome in primary health care in four Swedish counties.

Waehrens R, Ohlsson H, Sundquist J, Sundquist K, Zöller B.

Scand J Prim Health Care. 2013 Sep;31(3):132-7. doi: 10.3109/02813432.2013.811949. Epub 2013 Aug 2.

12.

Rome III survey of irritable bowel syndrome among ethnic Malays.

Lee YY, Waid A, Tan HJ, Chua AS, Whitehead WE.

World J Gastroenterol. 2012 Nov 28;18(44):6475-80; discussion p. 6479. doi: 10.3748/wjg.v18.i44.6475.

13.

Irritable bowel syndrome: diagnosis and pathogenesis.

El-Salhy M.

World J Gastroenterol. 2012 Oct 7;18(37):5151-63. doi: 10.3748/wjg.v18.i37.5151.

14.

Psychopharmacological treatment and psychological interventions in irritable bowel syndrome.

Sinagra E, Romano C, Cottone M.

Gastroenterol Res Pract. 2012;2012:486067. doi: 10.1155/2012/486067. Epub 2012 Aug 22.

15.

Subtypes and Symptomatology of Irritable Bowel Syndrome in Children and Adolescents: A School-based Survey Using Rome III Criteria.

Rajindrajith S, Devanarayana NM.

J Neurogastroenterol Motil. 2012 Jul;18(3):298-304. doi: 10.5056/jnm.2012.18.3.298. Epub 2012 Jul 10.

16.

Irritable Bowel Syndrome in Iran: SEPAHAN Systematic Review No. 1.

Jahangiri P, Jazi MS, Keshteli AH, Sadeghpour S, Amini E, Adibi P.

Int J Prev Med. 2012 Mar;3(Suppl 1):S1-9.

17.

Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.

Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, Beglinger C, Lehmann FS.

BMC Gastroenterol. 2012 Jan 10;12:5. doi: 10.1186/1471-230X-12-5.

18.

The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls.

Cash BD, Rubenstein JH, Young PE, Gentry A, Nojkov B, Lee D, Andrews AH, Dobhan R, Chey WD.

Gastroenterology. 2011 Oct;141(4):1187-93. doi: 10.1053/j.gastro.2011.06.084. Epub 2011 Jul 14.

19.

Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.

Sainsbury A, Ford AC.

Therap Adv Gastroenterol. 2011 Mar;4(2):115-27. doi: 10.1177/1756283X10387203.

20.

Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study.

Nørgaard M, Farkas DK, Pedersen L, Erichsen R, de la Cour ZD, Gregersen H, Sørensen HT.

Br J Cancer. 2011 Mar 29;104(7):1202-6. doi: 10.1038/bjc.2011.65. Epub 2011 Feb 22.

Supplemental Content

Support Center